Recent studies have implicated a role of norepinephrine (NE) in the activation of the sodium 29 chloride cotransporter (NCC) to drive the development of salt-sensitive hypertension. However, 30 the interaction between NE and increased salt intake on blood pressure remains to be fully 31 elucidated. This study examined the impact of a continuous NE infusion on sodium homeostasis 32 and blood pressure in conscious Sprague-Dawley rats challenged with a normal (NS; 0.6% 33 NaCl) or high salt (HS; 8% NaCl) diet for 14-days. Naïve and saline infused Sprague-Dawley 34 rats remained normotensive when placed on HS and exhibited dietary sodium-evoked 35 suppression of peak natriuresis to hydrochlorothiazide. NE infusion resulted in the development 36 of hypertension, which was exacerbated by HS, demonstrating the development of the salt-37 Sodium chloride cotransporter (NCC); salt-sensitive hypertension; norepinephrine; sodium 54 homeostasis; sympathetic nervous system 55 56
INTRODUCTION
femoral artery cannula (N=6/group; 15, 38). In figures 1A, 4A and 6A, the presented value for 173 MAP represents the average obtained over the entire 30-min period in which baseline MAP was 174
recorded. 175
Renal Sodium Transporter Activity: Following the completion of the cardiovascular function 176 protocol, a renal sodium transporter activity protocol was initiated. All animals received a control 177 i.v. infusion of isotonic saline (flow rate 20μl/min) for 1-h, followed by an i.v. bolus of amiloride 178 screen that allowed separation of food and feces from urine that was collected into beakers that 206 contained a layer of mineral oil to prevent evaporation. Rats were given ad libitum access to 207 their respective assigned diet and tap water for 24-h. Measurements were made for food and 208 water consumption and urine output during the 24-h period (15, 38) . Daily water balance was 209 determined by calculating the difference between water intake and urine output. Daily sodium 210 balance was determined by calculating the difference between sodium intake (dietary sodium 211 intake) and sodium output (urinary sodium excretion). 212
213

Analytical Techniques 214
Urine volume was determined gravimetrically assuming 1g = 1ml. Urinary and plasma sodium 215 concentration was measured by flame photometry (model 943, Instrumentation Laboratories, 216
Bedford, MA, USA; 15, 37, 38). Plasma hematocrit (Hct) was determined using a micro-217 hematocrit centrifuge (Adams Readacrit, Clay Adams, NJ, USA). Hct was used to calculate 218 estimated plasma volume (EPV) and estimated blood volume (EBV) using the following 219 equations: EPV = (0.065 x body weight (kg)) x (100 -Hct), EBV = (EPV x 100)/(100-Hct) (37). 220
Plasma Renin Activity and Plasma Norepinephrine Measurement 222
In separate groups of animals, naïve Sprague-Dawley and NE infused Sprague-Dawley rats 223 were placed on a NS or HS diet for the 14-day experimental protocol. At the end of the 14-day 224 experimental period, animals were decapitated while conscious and whole blood was collected. 225
Plasma renin activity was determined via ELISA (Immuno-Biological Labs America, 226
Minneapolis, MN, USA; cat#IB59131). Plasma NE content was determined via ELISA (Immuno-227
Biological Labs America, Minneapolis, MN, USA; cat#IB89552) 228
229
Kidney Cortical Membrane Preparation 230
Kidneys were harvested from animals following completion of acute experimental protocols (see 231 above) and stored at -80 o C. Kidney cortex tissue (~200mg) was homogenized on ice using a 232 hand held pestle in a homogenizing buffer (10mM triethanolamine, 250mM sucrose, 100mM 233 anti-β-actin (1:5000; Sigma, St. Louis, MO, USA; cat#A5316) in 0.1% PBS-T. Subsequently, 244 membranes were exposed to either a secondary horseradish peroxidase donkey anti-rabbit IgG 245 (H+L) (1:5000; Promega, Madison, WI, USA; cat#V7951) or anti-mouse IgG peroxidase 246 antibody (1:10000; Sigma, St. Louis, MO, USA; cat#A9044) in 0.1% PBS-T for 1-h at room 247 temperature. Bound antibodies were visualized using chemiluminescence (GE signal enhancer, 248
Buckinghamshire, UK). Densitometric analysis was performed using Quantity One software 249 (Bio-Rad, Hercules, CA, USA) and band densities were normalized to β-actin. 250
Statistical Analysis 251
Data are expressed as mean±SEM. Differences between groups were assessed by a 1-way 252 ANOVA, followed by a Tukey post-hoc test, to compare variations among the groups. A two-253 tailed Student's t-test was used to assess the difference between diet groups for the NCC 254 expression quantification. Statistical analysis was carried out using a software program 255 (GraphPad Prism version 6; GraphPad software, La Jolla, CA, USA). Statistical significance is 256 defined as p<0.05. 257
258
RESULTS
259
High salt intake exacerbates norepinephrine-induced hypertension 260 When naïve or s.c. infused saline treated Sprague-Dawley rats were challenged with a HS diet 261 for 14-days, we did not detect any difference in baseline MAP compared to animals maintained 262 on a NS diet ( Figure 1A) . In contrast to a s.c. saline infusion, a 14-day s. The s.c. infusion of NE caused a significant reduction in the slope of the chronic pressure-270 natriuresis relationship in Sprague-Dawley rats ( Figure 1B) , reflecting the increased salt-271 sensitivity of blood pressure. Additionally, Sprague-Dawley rats placed on a HS diet or receiving 272 a s.c. NE infusion showed no significant differences in 24-h sodium or water balance (Table 1) . 273
Further, the combination of a s.c. NE infusion and increased salt intake did not significantly alter 274 24-h sodium or water balance (Table 1) . When estimated plasma (EPV) and blood volume 275 (EBV) was calculated in these groups of animals we observed no significant effect of increased 276 dietary sodium intake or NE infusion, alone or in combination, on EPV or EBV (Table 2) . 277
278
Norepinephrine infusion prevents dietary sodium-evoked suppression of NCC activity 279
To assess the impact of NE infusion on vascular tone, we challenged animals with the 280 ganglionic blocker, hexamethonium, via an acute i.v. bolus injection. As illustrated (Figure 2A) , 281 increased dietary sodium intake did not alter the peak depressor response following ganglionic 282 blockade in naïve and s.c. saline infused Sprague-Dawley rats. However, NE infusion 283 significantly increased the peak depressor response to hexamethonium, a response that was 284 not altered following 14-days of HS intake ( Figure 2A ). Next, we assessed the impact of NE 285 infusion on the activity of two key renal sodium transporters, ENaC and NCC. s.c. NE+HS: 136±2). Additionally, plasma renin activity (PRA) and plasma NE content was 299 determined in naïve and NE infused Sprague-Dawley rats. Naïve rats showed a significant 300 decrease in PRA and plasma NE content when challenged with a HS diet (Table 3) . Rats 301 receiving a NE infusion maintained on either a NS or HS diet showed a significant decrease in 302
PRA when compared to naïve Sprague-Dawley rats on NS (Table 3 ). In NE-infused rats, we 303 observed increased plasma NE levels in animals maintained on both NS and HS compared to 304 naïve Sprague-Dawley rats (Table 3) . alter 24-h sodium or water balance regardless of salt intake (Table 1) . When estimated plasma 338 (EPV) and blood volume (EBV) was calculated in these groups of animals, we observed no 339 significant effect of increased dietary sodium intake or drug infusion on EPV or EBV (Table 4) . The key finding of this study is that excess plasma NE levels in combination with a high 358 dietary salt intake results in the development of salt-sensitive hypertension in the Sprague-359
Dawley rat, which exhibits a salt-resistant phenotype (37, 38). In the present study, we 360 demonstrate that in this animal model, a s.c. NE infusion alone evoked hypertension, the 361 magnitude of which was exacerbated when NE infused rats were placed on a HS diet, 362 demonstrating the development of the salt-sensitivity of blood pressure. In these animals, 363 increased plasma NE content prevented dietary sodium-evoked suppression of NCC, but not 364
ENaC activity, suggesting a role for the NCC in the observed development of salt-sensitive 365 hypertension. In agreement with a prior report in rats (30), and in contrast to studies in mice (22,32), NE infusion alone did not increase NCC protein expression in animals maintained on a NS 367 diet. Significantly, dietary sodium-evoked suppression of NCC expression was abolished in 368 animals challenged with NE and an elevated salt intake for 14-days, a response correlating with 369 impaired NCC activity and salt-sensitivity. Confirming a direct role of the NCC in the 370 development of NE-evoked salt-sensitive hypertension, chronic NCC antagonism with HCTZ 371 abolished the salt-sensitive component of NE-mediated hypertension. Chronic antagonism of 372 AT1 receptors with losartan was unable to restore NCC function, however AT1 receptor 373 blockade was able to significantly reduce NE-evoked increases in MAP in animals maintained 374 on either a NS or HS diet. Collectively, these data show a critical interaction between dietary 375 salt intake and circulating levels of NE that prevents the downregulation of NCC activity and 376 expression to evoke the development of salt-sensitive hypertension in the Sprague-Dawley rat. Notably, EPV and EBV was not impacted by 14-days of dietary sodium intake or NE infusion in 388 these studies. These data suggest that the observed increases in MAP after the 14-day protocol 389
are not dependent on a long-term increase in blood or plasma volume. However, these studies 390 do not rule out the possibility that transient increases in EPV and/or EBV play a role in the 391 induction and/or development of NE-evoked hypertension. To further investigate themechanisms contributing to elevated MAP in these NE infused animals, we assessed the 393 impact of hexamethonium-mediated ganglionic blockade on the peak depressor response. In 394 these studies we observed no difference in the peak depressor response following ganglionic 395 blockade between NE infused animals maintained on either a NS or HS diet. In NE infused 396 animals we observed a significantly greater drop in blood pressure versus that observed in 397 saline infused rats, indicating that increased vasoconstriction contributes to the development of 398 NE-evoked hypertension. As observed in control (naïve and saline infused) animals, a HS 399 intake did not significantly affect the depressor response to ganglionic blockade in NE infused 400 rats, suggesting that there is no impact of sodium intake to increase sympathetic outflow in NE 401 infused animals. As such, we believe the difference in basal blood pressure observed following 402 ganglionic blockade between NE infused animals on NS versus HS is reflective of the baseline 403 blood pressure differences observed prior to hexamethonium administration versus intrinsic 404 differences in sympathetic activity. The mechanism underlying our observation of an enhanced 405 depressor response post-ganglionic blockade in NE infused animals remains to be determined 406 and highlights the complexity of interpreting the results of ganglionic blockade in the setting of 407 chronic hypertension. In the current experimental paradigm, it would be anticipated that NE 408 infusion would not activate the sympathetic nervous system and may evoke reduced 409 sympathetic outflow. Therefore, we speculate that vascular hypertrophy, as has been reported 410 following Ang II-evoked persistent increases in blood pressure (21), may underlie the enhanced 411 response to ganglionic blockade observed in these studies. 412
Owing to reports that the Dahl salt-sensitive rat, which exhibits salt-sensitive 413 hypertension and increased plasma NE content (38), exhibits a failure to downregulate certain 414 ENaC subunits during high salt intake (1, 39), we elected to examine the activity of the ENaC in 415 hypertensive NE infused Sprague-Dawley rats. Our physiological data, generated in conscious 416 animals, indicates that the combination of a NE infusion and a HS intake does not prevent 417 sodium-evoked downregulation of the activity of the ENaC. These data suggest that in theamiloride) is not involved in the development of NE-evoked salt-sensitive hypertension, a finding 420 in contrast to the ENaC dysregulation observed in the Dahl salt-sensitive rat phenotype (1, 3) . 421
The differences between the previously reported impact of salt intake on ENaC in the Dahl salt-422 sensitive rat and our current report of a lack of effect during chronic NE infusion in the Sprague-423
Dawley rat may be attributed to 1) the genetic differences between the Dahl salt-sensitive and 424
Sprague-Dawley rat and 2) the multifactorial nature of Dahl salt-sensitive hypertension featuring 425 aberrations in central, vascular, cardiac, hormonal and renal mechanisms. We elected not to 426 determine renal ENaC subunit expression or to examine the impact of chronic ENaC inhibition 427 on the development of NE-evoked salt-sensitivity of blood pressure in the Sprague-Dawley rat 428 for the following reasons: 1) we observed no significant physiological differences in our NE 429 infusion model when compared to control animals in terms of the response of ENaC function 430 during HS intake and 2) a prior report stating that chronic ENaC inhibition did not prevent the 431 development of NE-evoked salt-sensitive hypertension in mice (22). 432 Therefore, our next series of studies focused on the role of the NCC in the development 433 of the salt-sensitivity of blood pressure in the Sprague-Dawley rat. Our initial data demonstrate 434 that on a NS intake, the infusion of NE, which evokes hypertension, does not alter the activity 435
(assessed as peak natriuresis to HCTZ) or expression (assessed via immunoblotting) of the 436 NCC. These data support the prior findings that chronic NE exposure does not alter NCC 437 expression in the Sprague-Dawley rat (30) or in mice (33). These data are in direct contrast to 438 data generated in mice reporting that total expression and phosphorylation of NCC is increased 439 by both chronic (22) and acute increases in NE (32). We believe the discrepancy between our 440 data and the data of other laboratories concerning the impact of NE on the expression of the 441 NCC may reflect, in part, a potential species difference in the mechanistic effects of NE on NCC 442 expression. In support of previous studies demonstrating that a HS intake evokes 443 downregulation of the NCC (40), we observed the downregulation of NCC activity (assessed aspeak natriuresis to HCTZ) and protein expression (assessed via immunoblotting) in naïve 445
Sprague-Dawley rats challenged with a HS diet. In contrast, animals that received a NE infusion 446 and a HS diet failed to downregulate the activity of the NCC during HS intake, suggesting a role 447 of impaired NCC function in the pathophysiology of sympathetically-mediated salt-sensitive 448 hypertension. These data suggest, that in the Sprague-Dawley rat, contrary to prior 449 observations in mice, the NCC evokes the development of salt-sensitive hypertension through a 450 failure to be downregulated in response to an elevated salt intake versus a direct action of NE to 451 increase activity and expression of the NCC. We acknowledge that these studies cannot 452 exclude a potential direct effect of increased blood pressure, occurring independently of an 453 interaction between salt and NE, that is influencing the activity of the NCC. To confirm a direct 454 role of the failure to downregulate the activity of the NCC in response to HS in the development 455 of salt-sensitivity, we conducted additional studies in which the NCC was chronically 456
antagonized by co-infusing Sprague-Dawley rats with NE & HCTZ for 14-days. The chronic 457 antagonism of the NCC abolished the salt-sensitive component of NE-mediated hypertension 458 and significantly attenuated the reduction in the slope of the chronic pressure-natriuresis 459 relationship. These data provide strong evidence that the NCC plays a key role in the 460 sympathetically-mediated regulation of the kidney to drive the development of salt-sensitive 461
hypertension. 462
In order to determine the potential contribution of the RAS in this animal model of NE-463 mediated salt-sensitive hypertension, we co-infused Sprague-Dawley rats with NE & losartan, 464 an AT1 receptor antagonist. The co-infusion of NE & losartan significantly decreased MAP in 465 animals maintained on both NS and HS diets versus animals receiving a NE infusion. Our data, 466
indicating the suppression of PRA activity during NE infusion, raises the paradoxical issue of 467 how AT1 antagonism reduces blood pressure in the setting of low renin/AngII levels. These data 468 are in line with prior studies that have demonstrated the efficacy of AT1 antagonism in multiple 469 models of "low renin" hypertension and we believe that further studies, beyond the scope of thecurrent manuscript, are required to determine the mechanism underlying the apparent counter-471 intuitive abolishment of hypertension during NE infusion by AT1 antagonism. However, when 472 Sprague-Dawley rats receiving a NE & losartan co-infusion were acutely challenged with HCTZ, 473 dietary sodium-evoked suppression of NCC activity was not observed. These data indicate that 474 the failure of the NCC to be downregulated in response to increased dietary salt intake during 475
NE infusion occurs independently of the actions of the RAS. Previous studies have reported that 476
AngII has direct effects on the abundance, activity, and regulation of the NCC (10, 35, 36) . 477
However, a recent study utilizing AngII receptor type 1a (AT1a) knockout mice reported that NE-478 induced effects on NCC expression and phosphorylation are not AT1a dependent (32). These 479 data support our results, which also indicate that the effects of NE on the NCC are independent 480 of AngIl. Further, the ability of losartan to prevent NE-evoked hypertension, but not restore HS 481 stimulated downregulation of NCC activity, suggests that NCC activity is regulated by NE via a 482 mechanism that is independent of increased blood pressure. Low dose AngII infusion results in 483 hyponatremia in Sprague-Dawley rats (23), in the current studies plasma Na + levels in NE 484 infused rats remained within the normal range (135-145mmol/L) suggesting that in our NE 485 infusion model we are not evoking systemic increases in AngII, at least not to a level that 486 evokes hyponatremia, a hypothesis supported by the NE-evoked suppression of PRA. Our data 487 on the suppression of PRA activity during NE infusion and HS intake substantiates a lack of 488 activation of the RAS in our experimental paradigm. The actions of NE to impact the NCC have 489 been suggested to be dependent on the actions of the β-adrenergic receptor (βAR) (22, 32). Mu 490 et al. (2011) reported that stimulation of the β2AR increased NCC activity and sodium retention 491 during the development of salt-sensitive hypertension in mice. However, a recent study has 492 suggested that the β1AR is primarily responsible for mediating the effects of NE on the NCC 493 due to the fact that β1ARs are highly enriched in the DCT (32). Currently, the β-adrenergic 494 receptor subtype responsible for mediating the effects of NE on the NCC remains to bedefinitively established, as does the impact of dietary salt intake and NE on the renal expression 496 of β-adrenergic receptors. 497
In conclusion, our results highlight the importance of the interaction between NE and 498 salt, and not just NE alone, to influence the function and expression of the NCC during the 499 pathophysiology of salt-sensitive hypertension. Although we believe our results are based on an 500 action of NE directly on NCC regulation, we cannot exclude a direct effect of blood pressure 501 preventing the downregulation of the NCC independently of an interaction between salt and NE. 502
In the current studies, NE is being increased systemically, not just locally at the level of the 503 kidney, as such, we are unable to rule out extra-renal effects and acknowledge that circulating 504 NE may not penetrate the kidney to the same extent as local release of NE from sympathetic 505 nerve terminals. However, given that in salt-sensitive human and rat (Dahl salt-sensitive) 506 subjects there is global sympathoexcitation (6, 11), and that our model of s.c. NE infusion is 507 directly comparable with prior studies published in rats (30) and mice (22, 33), we believe we 508
have developed a suitable model to investigate the actions of both salt and NE on sodium 509 homeostasis and blood pressure regulation. Despite the clinical use and well-defined 510 transporter specific diuretic actions of both HCTZ and amiloride, we recognize this series of 511 studies relies on their selectivity and that off-target effects must be considered when interpreting 512 the results. Owing to the short-term infusion of amiloride and HCTZ during the acute 513 experimental protocol, we speculate the off-targets actions of these drugs are likely limited. In 514 regard to the 14-day infusion of HCTZ, we observed no overt signs of potential hypokalemia that 515 could have impacted our studies. In future studies, beyond the scope of the current 516 investigations, we plan to address the effects of NE and salt on NCC function and expression in 517 additional rat models of salt-sensitive hypertension (e.g. Dahl salt-sensitive rat vs. Dahl salt-518 resistant rat). Future studies will also be conducted to investigate the impact of salt and NE on 519 the phosphorylation of NCC via SPAK (SPS1-related proline/alanine rich kinase) and OxSR1 520 (oxidative stress response-1) in our animal model to allow for further clarification of themechanism(s) contributing to the observed dysregulation of NCC activity in Sprague-Dawley 522 rats during NE infusion and high dietary sodium intake. 523
524
Perspectives 525
The current data highlight the critical interaction between dietary salt intake and increased levels 526 of NE on the activity of the NCC. This work extends our understanding of interactions between 527 the sympathetic nervous system and the kidney in the long-term regulation of sodium 528 homeostasis and blood pressure. These findings challenge recent reports generated in mice of 529 a direct effect of NE to increase expression of the NCC and substantiate this species difference 530 in the response of NCC protein levels to NE infusion. We demonstrate that there is no effect of 531 NE infusion alone on the physiological activity of the NCC in-vivo in conscious Sprague-Dawley 532 rats. Our data suggest a crucial impact of NE in preventing the sodium-evoked suppression of 533 NCC activity and expression and support a key role for the NCC in the pathophysiology of salt-534 sensitive hypertension via actions of the sympathetic nervous system on the kidney. These 535 findings suggest that there are significant species differences in the response to NE and 536 highlight the importance of using multiple animal models to investigate the origins and 537 mechanisms underlying salt-sensitivity. We speculate that in hypertensive patients with 538 increased activity of the sympathetic nervous system, there may be an increased risk of 539 developing salt-sensitivity versus patients in which sympathetic activity remains unchanged, 540 possibly using elevated plasma NE levels as a marker of future salt-sensitivity. Dawley rats and in Sprague-Dawley rats receiving either a s.c. isotonic saline infusion or a s.c. 697 norepinephrine (NE; 600ng/min) infusion maintained on either a normal (0.6% NaCl) or high salt 698 (8% NaCl) diet for 14 days. Data are mean ± SEM (N=6/group). *p<0.05 vs. respective 0.6% 699 NaCl group value; τp<0.05 vs. respective naive group value; φp<0.05 vs. respective saline 700 group value. 701 (0.6% NaCl) or high salt (8% NaCl) diet for 14 days. Data are mean ± SEM (N=6/group). 708 *p<0.05 vs. respective 0.6% NaCl group value; τp<0.05 vs. respective naive group value; 709 φp<0.05 vs. respective saline group value. 710 Sprague-Dawley rats receiving either a s.c. isotonic saline or norepinephrine (NE; 600ng/min) 713 infusion maintained for 14-days on a normal (0.6% NaCl) or high salt (8% NaCl) diet. Data are 714 mean ± SEM (N=6/group). *p<0.05 vs. respective 0.6% NaCl group value. 
